Olopatadine hydrochloride and Keloids - a phase IV clinical study of FDA data
Keloids is reported only by a few people who take Olopatadine Hydrochloride.
The phase IV clinical study analyzes which people take Olopatadine hydrochloride and have Keloids. It is created by eHealthMe based on reports of 3,757 people who have side effects while taking Olopatadine hydrochloride from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,757 people reported to have side effects when taking Olopatadine hydrochloride.
Among them, 1 person (0.03%) has Keloids.
What is Olopatadine hydrochloride?
Olopatadine hydrochloride has active ingredients of olopatadine hydrochloride. eHealthMe is studying from 3,777 Olopatadine hydrochloride users for its effectiveness, alternative drugs and more.
What is Keloids?
Keloids (overgrown scars left from skin injuries) is found to be associated with 633 drugs and 453 conditions by eHealthMe.
Number of Olopatadine hydrochloride and Keloids reports submitted per year:
Gender of people who have Keloids when taking Olopatadine hydrochloride *:
- female: 0.0 %
- male: 100 %
Age of people who have Keloids when taking Olopatadine hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 100 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common side effects people have besides Keloids *:
- Rhinorrhea (watery mucus discharge from the nose): 1 person, 100.00%
- Oropharyngeal Discomfort (pain or irritation of oropharynx): 1 person, 100.00%
- Nausea (feeling of having an urge to vomit): 1 person, 100.00%
- Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 100.00%
- Generalised Erythema (redness of the skin all over the body): 1 person, 100.00%
- Breathing Difficulty: 1 person, 100.00%
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 100.00%
- Allergic Rhinitis: 1 person, 100.00%
Common conditions people have *:
- Allergic Rhinitis: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Olopatadine hydrochloride and have Keloids?Check whether Keloids is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keloids and when was it recovered:
Expand to all the drugs that have ingredients of olopatadine hydrochloride:
Alternative drugs to, pros and cons of Olopatadine hydrochloride:
- Olopatadine hydrochloride (3,777 reports)
Common Olopatadine hydrochloride side effects:
- Drug ineffective: 197 reports
- Rashes (redness): 156 reports
- Fever: 133 reports
- Pneumonia: 117 reports
- Malaise (a feeling of general discomfort or uneasiness): 101 reports
Browse all side effects of Olopatadine hydrochloride:a b c d e f g h i j k l m n o p q r s t u v w x y z
Keloids treatments and more:
- Keloids (1,005 reports)
COVID vaccines that are related to Keloids:
- Keloids in Moderna COVID Vaccine
- Keloids in Pfizer BioNTech Covid Vaccine
- Keloids in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keloids:
- Keloids (633 drugs)
All the conditions that are associated with Keloids:
- Keloids (453 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on olopatadine hydrochloride (the active ingredients of Olopatadine hydrochloride) and Olopatadine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Co-Codamol and Oral Disorder - 5 seconds ago
- Spironolactone and Hypotension Aggravated - 6 seconds ago
- Nevirapine and Back Pain - 7 seconds ago
- Dexilant and Invokana drug interaction - 7 seconds ago
- Febuxostat and Primidone drug interaction - 16 seconds ago
- Ritalin and Amrix drug interaction - 26 seconds ago
- Penicillamine and Memory Loss - 33 seconds ago
- Fluvoxamine Maleate and Aspirin drug interaction - 34 seconds ago
- Nystatin and Mumps - 35 seconds ago
- Isosorbide Mononitrate and Stress Symptoms - 44 seconds ago